Detalhe da pesquisa
1.
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Breast Cancer Res Treat
; 205(3): 589-598, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456970
2.
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
Eur J Nucl Med Mol Imaging
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587643
3.
Tumor mutational burden as predictive factor of response to immunotherapy.
Transl Lung Cancer Res
; 7(Suppl 4): S358-S361, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705855